Free Trial

ESSA Pharma (EPIX) Short Interest Ratio & Short Volume

→ Write this ticker symbol down… (From StocksToTrade) (Ad)
Free EPIX Stock Alerts
$5.72
-0.10 (-1.72%)
(As of 06/7/2024 08:51 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends

ESSA Pharma Short Interest Data

Current Short Interest
913,100 shares
Previous Short Interest
926,500 shares
Change Vs. Previous Month
-1.45%
Dollar Volume Sold Short
$5.66 million
Short Interest Ratio
13.9 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
44,360,000 shares
Percentage of Shares Shorted
2.06%
Today's Trading Volume
47,800 shares
Average Trading Volume
113,861 shares
Today's Volume Vs. Average
42%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ESSA Pharma ?

Sign up to receive the latest short interest report for ESSA Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

EPIX Short Interest Over Time

EPIX Days to Cover Over Time

EPIX Percentage of Float Shorted Over Time

ESSA Pharma Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024913,100 shares $5.66 million -1.5%N/A13.9 $6.20
4/30/2024926,500 shares $5.96 million +20.4%N/A8.7 $6.43
4/15/2024769,300 shares $5.62 million -4.2%N/A5.8 $7.30
3/31/2024802,800 shares $6.82 million -13.6%N/A5.2 $8.49
3/15/2024928,600 shares $8.36 million -5.2%4.6%6.1 $9.00
2/29/2024979,400 shares $9.30 million -13.3%4.8%6.3 $9.50
2/15/20241,130,000 shares $11.25 million -19.9%5.6%7.4 $9.96
1/31/20241,410,000 shares $11.69 million +5.2%7.1%9.5 $8.29
1/15/20241,340,000 shares $13.32 million No Change6.7%7.8 $9.94
12/31/20231,340,000 shares $8.84 million -1.5%6.7%6.9 $6.60
12/15/20231,360,000 shares $8.47 million -2.9%6.8%7.1 $6.23
11/30/20231,400,000 shares $7.45 million +1.5%7.0%7.7 $5.32
11/15/20231,380,000 shares $7.25 million +1.5%6.9%7.8 $5.25
10/31/20231,360,000 shares $6.32 million +3,959.7%6.8%8.3 $4.65
10/15/202333,500 shares $91,790.00 -32.5%0.2%0.3 $2.74
9/30/202349,600 shares $153,264.00 +73.4%0.3%1.7 $3.09
9/15/202328,600 shares $75,790.00 -4.7%0.1%0.9 $2.65
8/31/202330,000 shares $90,000.00 -42.2%0.2%0.9 $3.00
8/15/202351,900 shares $159,852.00 +8.1%0.3%1.4 $3.08
7/31/202348,000 shares $144,960.00 -29.1%0.2%1.3 $3.02
7/15/202367,700 shares $192,945.00 -27.9%0.4%1.7 $2.85
6/30/202393,900 shares $253,530.00 -21.6%0.5%1.9 $2.70
6/15/2023119,700 shares $389,025.00 -18.5%0.6%2.2 $3.25
5/31/2023146,900 shares $440,700.00 -14.1%0.8%2.2 $3.00
5/15/2023171,000 shares $499,320.00 -11.2%0.9%2.3 $2.92
4/30/2023192,600 shares $529,650.00 -33.8%1.0%1.7 $2.75
4/15/2023290,900 shares $805,793.00 +2.8%1.6%1.9 $2.77
3/31/2023282,900 shares $840,213.00 -1.4%1.5%1.4 $2.97
3/15/2023287,000 shares $826,560.00 +21.2%1.5%1.3 $2.88
2/28/2023236,800 shares $796,832.00 +17.0%1.3%1 $3.37
2/15/2023202,400 shares $718,520.00 -26.6%1.1%0.7 $3.55
1/31/2023275,800 shares $783,272.00 -20.6%1.5%0.9 $2.84
1/15/2023347,500 shares $966,050.00 -1.6%1.9%0.1 $2.78
12/30/2022353,000 shares $889,560.00 -18.1%1.9%0.1 $2.52
12/15/2022431,100 shares $1.22 million -20.9%2.3%0.1 $2.84
11/30/2022545,000 shares $2.01 million -11.9%2.9%0.2 $3.69
11/15/2022618,300 shares $2.46 million -69.4%3.3%0.2 $3.98
10/31/20222,020,000 shares $7.27 million +472.9%11.6%0.6 $3.60
10/15/2022352,600 shares $691,096.00 -5.7%2.0%2.1 $1.96
9/30/2022373,800 shares $680,316.00 +5.4%2.2%1.5 $1.82
It's time to ween off Chinese lithium! (Ad)

As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely

Learn how this American company is leading the lithium-ion revolution
9/15/2022354,500 shares $794,080.00 -5.5%2.0%0.9 $2.24
8/31/2022375,000 shares $967,500.00 +28.1%2.2%1 $2.58
8/15/2022292,800 shares $878,400.00 -8.7%1.7%0.7 $3.00
7/31/2022320,800 shares $907,864.00 -3.2%1.9%0.8 $2.83
7/15/2022331,400 shares $1.05 million -85.2%1.9%0.8 $3.17
6/30/20222,240,000 shares $7.06 million -4.7%12.9%7.4 $3.15
6/15/20222,350,000 shares $10.55 million -7.1%13.5%10.2 $4.49
5/31/20222,530,000 shares $12.78 million +1.2%14.6%9.5 $5.05
5/15/20222,500,000 shares $14.78 million +11.6%14.4%10 $5.91
4/30/20222,240,000 shares $12.70 million +4.7%13.1%9.1 $5.67
4/15/20222,140,000 shares $16.16 million +13.2%12.5%8.7 $7.55
3/31/20221,890,000 shares $11.68 million +81.7%11.0%6.9 $6.18
3/15/20221,040,000 shares $6.56 million +43.6%6.1%4.8 $6.31
2/28/2022724,100 shares $5.92 million +9.8%4.2%4 $8.17
2/15/2022659,800 shares $6.44 million +21.8%3.9%3.2 $9.76
1/31/2022541,800 shares $5.04 million -17.7%3.2%2.1 $9.31
1/15/2022658,100 shares $6.13 million -8.6%3.8%2.5 $9.32
12/31/2021720,200 shares $10.23 million -10.1%4.3%3.1 $14.20
12/15/2021800,900 shares $10.36 million -23.0%4.8%3.2 $12.94
11/30/20211,040,000 shares $13.89 million +11.0%6.2%4 $13.36
11/15/2021937,100 shares $12.17 million -25.0%5.6%3.2 $12.99
10/29/20211,250,000 shares $11.38 million +8.7%7.6%2.5 $9.10
10/15/20211,150,000 shares $9.33 million +2.7%7.0%2.1 $8.11
9/30/20211,120,000 shares $8.96 million -8.2%6.8%1.9 $8.00
9/15/20211,220,000 shares $10.57 million +3.4%7.4%2.1 $8.66
8/31/20211,180,000 shares $11.19 million -28.9%7.2%2.1 $9.48
8/13/20211,660,000 shares $19.79 million +55.1%10.3%3.2 $11.92
7/30/20211,070,000 shares $23.94 million +10.0%6.7%3.5 $22.37
7/15/2021972,500 shares $24.25 million +11.5%6.1%4.1 $24.94
6/30/2021872,200 shares $24.92 million +7.6%5.5%3.9 $28.57
6/15/2021810,600 shares $21.76 million +417.6%5.1%3.6 $26.84
5/28/2021156,600 shares $4.95 million -7.8%1.0%0.6 $31.62
5/14/2021169,900 shares $4.61 million -37.3%1.1%0.7 $27.15
4/30/2021271,000 shares $8.35 million +47.0%1.8%0.8 $30.83
4/15/2021184,300 shares $4.91 million +13.5%1.2%0.5 $26.64
3/31/2021162,400 shares $4.98 million +9.1%1.1%0.4 $30.67
3/15/2021148,900 shares $4.78 million +139.4%1.0%0.4 $32.08
2/26/202162,200 shares $1.58 million -0.8%0.4%0.2 $25.43
2/12/202162,700 shares $1.80 million +37.5%0.4%0.2 $28.65
1/29/202145,600 shares $777,480.00 +8.3%0.3%0.2 $17.05
1/15/202142,100 shares $666,443.00 -38.4%0.3%0.2 $15.83
12/31/202068,300 shares $808,672.00 +349.3%0.5%0.5 $11.84
12/15/202015,200 shares $107,464.00 +149.2%0.1%0.1 $7.07
11/30/20206,100 shares $39,955.00 -47.0%0.0%0.1 $6.55
11/15/202011,500 shares $74,405.00 -9.5%0.1%0.1 $6.47
10/30/202012,700 shares $69,469.00 +84.1%0.1%0.1 $5.47
10/15/20206,900 shares $46,092.00 -64.1%0.1%0.1 $6.68
9/30/202019,200 shares $132,480.00 +62.7%0.1%0.1 $6.90
9/15/202011,800 shares $91,922.00 -51.4%0.1%0.1 $7.79
8/31/202024,300 shares $170,829.00 -20.9%0.2%0.2 $7.03
It's time to ween off Chinese lithium! (Ad)

As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely

Learn how this American company is leading the lithium-ion revolution
8/14/202030,700 shares $210,295.00 -38.8%0.2%0.3 $6.85
7/31/202050,200 shares $350,898.00 +63.5%0.3%0.6 $6.99
7/15/202030,700 shares $184,507.00 -6.1%0.2%0.7 $6.01
6/30/202032,700 shares $196,854.00 +23.9%0.2%1 $6.02
6/15/202026,400 shares $133,320.00 -1.9%0.2%1 $5.05
5/29/202026,900 shares $140,418.00 -3.6%0.2%1.1 $5.22
5/15/202027,900 shares $128,340.00 +4.1%0.2%1 $4.60
4/30/202026,800 shares $119,260.00 -6.0%0.2%0.8 $4.45
4/15/202028,500 shares $114,285.00 +1.1%0.2%0.9 $4.01
3/31/202028,200 shares $115,338.00 -40.3%0.2%0.8 $4.09
3/13/202047,200 shares $187,856.00 -1.1%0.3%1.2 $3.98
2/28/202047,700 shares $178,875.00 -1.0%0.3%1.4 $3.75
2/14/202048,200 shares $214,972.00 +3.0%0.4%1.2 $4.46
1/31/202046,800 shares $234,000.00 -44.8%0.3%1.3 $5.00
1/15/202084,800 shares $446,896.00 -8.3%0.6%2.1 $5.27
12/31/201992,500 shares $531,875.00 -23.0%0.7%2.2 $5.75

EPIX Short Interest - Frequently Asked Questions

What is ESSA Pharma's current short interest?

Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 913,100 shares of EPIX short. Learn More on ESSA Pharma's current short interest.

What is a good short interest ratio for ESSA Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EPIX shares currently have a short interest ratio of 14.0. Learn More on ESSA Pharma's short interest ratio.

Is ESSA Pharma's short interest increasing or decreasing?

ESSA Pharma saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 913,100 shares, a drop of 1.4% from the previous total of 926,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ESSA Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ESSA Pharma: Calliditas Therapeutics AB (publ) (0.03%), Day One Biopharmaceuticals, Inc. (17.50%), AbCellera Biologics Inc. (9.58%), Mirum Pharmaceuticals, Inc. (18.69%), Prothena Co. plc (12.11%), Collegium Pharmaceutical, Inc. (21.67%), Enliven Therapeutics, Inc. (19.75%), Cassava Sciences, Inc. (26.68%), Arcturus Therapeutics Holdings Inc. (16.81%), Ironwood Pharmaceuticals, Inc. (14.52%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short ESSA Pharma stock?

Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. EPIX shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ESSA Pharma?

A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further.

How often is ESSA Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:EPIX) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Write this ticker symbol down…
A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...
StocksToTrade | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
You won't believe what Citigroup just did to it's depositors
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...
American Alternative | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored